Written by Peter G. Traber, M.D. on August 17, 2015 Galectin Therapeutics is developing a drug called GR-MD-02 which binds to and inhibits the galectin-3 protein which is important in...
Read More The Potential for Treatment of Liver Fibrosis With Galectin’s Drug Candidate GR-MD-02
0 Comments , in Article
Written by Peter G. Traber, M.D. on July 31, 2015 Liver fibrosis is scar formation in the liver which, when it reaches a large amount of scar tissue (called cirrhosis),...
Read More
Written by Peter G. Traber, M.D. on July 31, 2015 During the normal course of conducting business in a public company like Galectin Therapeutics, as the CEO and Chief Medical...
Read More